FIELD: medicine. SUBSTANCE: method involves determining life duration in months using formula built as linear combination of several variables like morphological tumor parameters, namely, histological variant, stroma area, cell nucleus area, mitotic index, bcl-2 expression value. EFFECT: high accuracy of prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH HEPATICCELLULAR CARCINOMA | 2001 |
|
RU2207573C2 |
| PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
| LIFE SPAN PREDICTION METHOD FOR PATIENTS SUFFERING FROM MUCINOUS OVARIAN CARCINOMA | 2008 |
|
RU2354303C1 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
| METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
| MESONEPHROID OVARIAN CARCINOMA SPREAD PREDICTION METHOD | 2008 |
|
RU2354302C1 |
| METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
| METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS AND ENDOMETRIOID OVARIAN CARCINOMA | 2003 |
|
RU2263912C2 |
